Raffles Medical Group Ltd - Laporan Laba Rugi (TTM)

Raffles Medical Group Ltd
SG ˙ SGX
SGD 1.01 0.00 (0.00%)
2025-09-04
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Raffles Medical Group Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 541 568 619 671 698 725 758 791 808 825 805 786 747 708 706 703 728 752 759 765
Change (%) 5.09 9.01 8.27 4.07 3.91 4.55 4.35 2.14 2.09 -2.36 -2.42 -4.96 -5.22 -0.36 -0.36 3.52 3.40 0.85 0.84
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 408 427 456 485 508 530 540 549 487 425 389 353 373 392 392 392 403 413 415 417
Change (%) 4.83 6.73 6.30 4.67 4.46 1.80 1.77 -11.33 -12.78 -8.44 -9.22 5.52 5.23 -0.00 -0.00 2.72 2.65 0.38 0.38
% of Revenue 75.42 75.23 73.66 72.32 72.73 73.11 71.20 69.44 60.28 51.50 48.29 44.93 49.88 55.38 55.58 55.78 55.34 54.94 54.69 54.44
Gross Operating Profit 133 141 163 186 190 195 218 242 321 400 416 433 374 316 313 311 325 339 344 349
Change (%) 5.89 15.95 13.75 2.53 2.46 12.00 10.71 32.74 24.67 4.09 3.93 -13.51 -15.61 -0.80 -0.81 4.52 4.33 1.42 1.40
% of Revenue 24.58 24.77 26.34 27.68 27.27 26.89 28.80 30.56 39.72 48.50 51.71 55.07 50.12 44.62 44.42 44.22 44.66 45.06 45.31 45.56
SG&A 9 7 7 7 7 7 10 13 62 110 137 165 152 139 149 159 164 170 173 176
Change (%) -16.92 -2.71 -2.79 0.22 0.22 46.40 31.69 362.25 78.37 24.74 19.83 -7.90 -8.57 7.38 6.87 3.31 3.21 1.79 1.75
% of Revenue 1.62 1.28 1.15 1.03 0.99 0.96 1.34 1.69 7.65 13.36 17.07 20.96 20.31 19.59 21.11 22.65 22.60 22.56 22.77 22.97
R&D
Change (%)
% of Revenue
OpEx 471 497 532 568 587 607 625 643 627 612 597 582 591 600 615 630 649 667 674 680
Change (%) 5.62 7.10 6.63 3.46 3.34 2.95 2.86 -2.42 -2.48 -2.40 -2.46 1.51 1.48 2.52 2.46 2.95 2.87 0.93 0.92
% of Revenue 87.05 87.49 85.96 84.66 84.16 83.70 82.42 81.25 77.62 74.15 74.12 74.09 79.13 84.72 87.17 89.64 89.15 88.69 88.77 88.84
Operating Income 70 71 87 103 111 118 133 148 181 213 208 204 156 108 91 73 79 85 85 85
Change (%) 1.53 22.36 18.27 7.47 6.95 12.76 11.31 21.87 17.95 -2.25 -2.31 -23.44 -30.61 -16.33 -19.52 8.39 7.74 0.20 0.20
% of Revenue 12.95 12.51 14.04 15.34 15.84 16.30 17.58 18.75 22.38 25.85 25.88 25.91 20.87 15.28 12.83 10.36 10.85 11.31 11.23 11.16
Interest Expense -4 -5 -5 -5 -6 -6 -7 -7 -7 -7 -6 -6 -6 -6 -6 -7 -6 -6 -5 -5
Change (%) 21.60 1.52 1.50 9.85 8.97 5.24 4.98 -1.22 -1.23 -5.50 -5.82 -0.16 -0.16 3.65 3.52 -5.70 -6.04 -8.87 -9.73
% of Revenue -0.78 -0.91 -0.84 -0.79 -0.84 -0.88 -0.88 -0.89 -0.86 -0.83 -0.80 -0.78 -0.81 -0.86 -0.89 -0.93 -0.85 -0.77 -0.69 -0.62
Net Income 60 66 77 88 86 84 94 104 124 143 143 144 117 90 76 61 62 62 63 64
Change (%) 9.25 16.85 14.42 -2.23 -2.28 11.94 10.66 18.68 15.74 0.11 0.11 -18.59 -22.84 -16.20 -19.33 1.07 1.06 1.18 1.16
% of Revenue 11.15 11.60 12.43 13.14 12.34 11.61 12.43 13.18 15.31 17.36 17.80 18.26 15.64 12.73 10.71 8.67 8.46 8.27 8.30 8.33

Source: Capital IQ

Other Listings
US:RAFLF
DE:02M1
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista